These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7349893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S, Ogawa M, Sakurai Y.
    Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract] [Full Text] [Related]

  • 4. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S, Ogawa M, Hoshino A.
    Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic synergism elicited by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride: synergistic cytocidal activity against L1210 cells in vitro.
    Fujimoto S, Ogawa M.
    Gan; 1980 Oct; 71(5):659-66. PubMed ID: 6939645
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
    Akaike Y, Arai Y, Taguchi H, Satoh H.
    Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
    [Abstract] [Full Text] [Related]

  • 8. Effect of 3-[4-amino-2-methyl-5-pyrimidinyl)ethyl[-1(2-chloroethyl)-1-nitrosourea hydrochloride on lymphoid leukemia L-1210.
    Shimizu F, Arakawa M.
    Gan; 1975 Apr; 66(2):149-54. PubMed ID: 1150007
    [Abstract] [Full Text] [Related]

  • 9. DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hilton J, Bowie DL, Gutin PH, Zito DM, Walker MD.
    Cancer Res; 1977 Jul; 37(7 Pt 1):2262-6. PubMed ID: 861950
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antitumour activity of 4-nitroso-4-(2-chloroethyl)semicarbazides.
    Gugova RG, Raikov ZD, Zakhariev SG, Demirov GD, Todorov DK, Ilarionova MV.
    Drugs Exp Clin Res; 1989 Jul; 15(10):497-500. PubMed ID: 2632217
    [Abstract] [Full Text] [Related]

  • 11. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Fujimoto S, Ogawa M.
    Cancer Chemother Pharmacol; 1982 Jul; 9(3):134-9. PubMed ID: 6218931
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo DNA damage and resistance to 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in L1210 leukemia cells.
    Gorbacheva LB, Kukushkina GV, Durdeva AD, Ponomarenko NA.
    Neoplasma; 1988 Jul; 35(1):3-14. PubMed ID: 3127736
    [Abstract] [Full Text] [Related]

  • 14. Distribution of radiolabeled 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitros ourea hydrochloride in rat brain tumor: intraarterial versus intravenous administration.
    Yamada K, Ushio Y, Hayakawa T, Arita N, Huang TY, Nagatani M, Yamada N, Mogami H.
    Cancer Res; 1987 Apr 15; 47(8):2123-8. PubMed ID: 3470138
    [Abstract] [Full Text] [Related]

  • 15. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
    Inoue K, Fujimoto S, Ogawa M.
    Gan; 1980 Oct 15; 71(5):686-91. PubMed ID: 7227717
    [Abstract] [Full Text] [Related]

  • 16. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu, Sokolova IS, Bakhmedova AA, Miniker TD, Mel'nik SIa, Gorbacheva LB.
    Biokhimiia; 1995 Sep 15; 60(9):1521-9. PubMed ID: 8562657
    [Abstract] [Full Text] [Related]

  • 17. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
    Tanaka M, Nishigaki T, Nakajima E, Totsuka S, Nakamura K.
    Cancer Treat Rep; 1980 Sep 15; 64(4-5):575-80. PubMed ID: 6933003
    [Abstract] [Full Text] [Related]

  • 18. [Relation between the changes in the structure and synthesis of DNA in the cells of mouse leukemia L1210 induced by 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea].
    Durdyeva ED, Kukushkina GV, Gorbacheva KB.
    Biull Eksp Biol Med; 1986 Feb 15; 101(2):192-5. PubMed ID: 3947737
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
    Lin TS, Fischer PH, Marsh JC, Prusoff WH.
    Cancer Res; 1982 May 15; 42(5):1624-9. PubMed ID: 7066884
    [Abstract] [Full Text] [Related]

  • 20. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
    Yamaguchi T, Nakagawa M, Hidaka K, Yoshida T, Sasaki T, Akiyama S, Kuwano M.
    Jpn J Cancer Res; 1985 Oct 15; 76(10):1021-6. PubMed ID: 3935620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.